Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants
Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants: Breast augmentation
Study summary
This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria
* Genetic female.
* Patient is seeking one of the following procedures:
Primary Breast Augmentation Primary Breast Reconstruction Revision Augmentation Revision Reconstruction
* Patient has adequate tissue available to cover implant(s).
* Willingness to follow all study requirements including agreeing to attend all required follow-up visits and signs the informed consent.
* Agrees to have device returned to Establishment Labs if explanted.
* Willing to undergo Magnetic Resonance Imaging (MRI) evaluation of medically advised.
Exclusion Criteria:
* Has any breast disease considered to be pre-malignant in one or both breasts or is reporting mutations in BRCA1 or BRCA2 without a previous bilateral mastectomy or an untreated cancer of any type.
* Has inadequate or unsuitable tissue (e.g., due to radiation damage, ulceration compromised vascularity, history of compromised wound healing).
* Has an abscess or infection.
* Is pregnant or nursing or has had a full-term pregnancy or lactated within 6 months of enrollment.
* Is taking any drugs that would interfere with blood clotting, or that might result in elevated risk and or significant postoperative complications.
* Has any medical condition such as obesity (BMI ≥ 40), diabetes, autoimmune disease, chronic lung or severe cardiovascular disease that might result in unduly high surgical risk and or significant postoperative complications.
* Has any connective tissue/autoimmune disorder or rheumatoid disease, such as systemic lupus erythematosus, discoid lupus, scleroderma, or rheumatoid arthritis, among others.
* Has any condition that impedes the use of magnetic resonance imaging (MRI) including implanted metal device, claustrophobia or other conditions that would make MRI scan prohibited.
* Has a history of psychological characteristics that are unrealistic or unreasonable given the risks involved with the surgical procedure.
* Has been implanted with any non-FDA approved breast implant.
* Has been implanted with any silicone implant other than breast implants.
* HIV positive (based on medical history).
* Has been diagnosed with anaplastic large cell lymphoma (ALCL).
* Works for Establishment Labs, Motiva USA or any of their subsidiaries, the study surgeon, or ICON the Contract Research Organization (CRO) that is helping to conduct the study or are directly-related to anyone that works for Establishment Labs, Motiva USA or any of their subsidiaries, the study surgeon, or the CRO.
Primary outcome measure(s)
Analyze and report the total adverse events rate ("any complication)" of the Silicone Gel filled Motiva Implants®. Kaplan-Meier analysis of adverse events will be conducted by time period for each type of adverse event. — 10 Years
Analyze patient satisfaction on a 5-point Likert scale post-implant for all implantation groups. — 10 Years
Trial sites (29)
Facility
City
Region
Status
Gerald Minitti, MD, FACS
Beverly Hills
California
Steven Teitelbaum, MD, FACS
Santa Monica
California
Westlake Cosmetic Surgery Center
Westlake Village
California
The Center for Cosmetic Surgery
Golden
Colorado
Emory University Hospital
Atlanta
Georgia
Northwestern Plastic Surgery
Chicago
Illinois
Northwestern Specialists in Plastic Surgery, S.C.
Chicago
Illinois
Meridian Plastic Surgery Center
Indianapolis
Indiana
CaloAesthetics® Plastic Surgery Center
Louisville
Kentucky
The Wall Center for Plastic Surgery
Shreveport
Louisiana
Partners in Plastic Surgery of West Michigan
Grand Rapids
Michigan
Parkcrest Plastic Surgery
St Louis
Missouri
Glicksman Plastic Surgery
Sea Girt
New Jersey
Mark D. Epstein, MD, FACS/ Center for Aesthetic Surgery
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.